Climb Bio, Inc.
CLYM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001768446
In the last 90 days, Climb Bio, Inc. insiders filed 0 open-market purchases and 1 sale; 108 institutions reported holding it in 13F filings for Q2 2026, worth $734.3M in total; no superinvestor holds it.
Holders of 5% or more of CLYM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Climb Bio, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 13D/A | 33.00%23.9M shares | 0.00 ppfrom 33.00% | Aug 19, 202112 filings | Nov 9, 2026 | SEC |
| FMR LLC | 13G/A | 15.00%8.62M shares | +3.10 ppfrom 11.90% | Jul 8, 20262 filings | Nov 5, 2026 | SEC |
| Pontifax Management 4 G.P. (2015) Ltd. | 13G | 7.70%5.21M shares | New | Sep 18, 20251 filing | Sep 18, 2025 | SEC |
| Flynn James E | 13G | 5.25%3.07M shares | New | Oct 28, 20261 filing | Oct 28, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.00%2.90M shares | New | Oct 27, 20261 filing | Oct 27, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
38 Schedule 13D and 13G filings on Climb Bio, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 9, 20265:32 PM ET | Ra Capital Management, L.P.and 4 others | 13D/A | 33.00%23.9M shares | 0.00 ppfrom 33.00% | Nov 5, 2026 | SEC |
| Nov 5, 20261:14 PM ET | FMR LLCand 1 other | 13G/A | 15.00%8.62M shares | +3.10 ppfrom 11.90% | Sep 30, 2026 | SEC |
| Oct 28, 20268:51 AM ET | Flynn James Eand 3 others | 13G | 5.25%3.07M shares | New | Oct 27, 2026 | SEC |
| Oct 27, 20265:25 PM ET | BlackRock, Inc. | 13G | 5.00%2.90M shares | New | Sep 30, 2026 | SEC |
| Aug 14, 20264:02 PM ET | MPM Oncology Impact Management LP | 13G/A | 0.00%0 shares | −5.60 ppfrom 5.60%Below 5% | Jun 30, 2026 | SEC |
| Jul 8, 202610:11 AM ET | FMR LLCand 1 other | 13G | 11.90%6.79M shares | New | Jun 30, 2026 | SEC |
| Jul 7, 20264:41 PM ET | Ra Capital Management, L.P.and 4 others | 13D/A | 33.00%23.2M shares | 0.00 ppfrom 33.00% | Jul 2, 2026 | SEC |
| Apr 29, 20266:44 PM ET | Ra Capital Management, L.P.and 5 others | 13D/A | 33.00%22.6M shares | 0.00 ppfrom 33.00% | Apr 27, 2026 | SEC |
| Feb 17, 20264:09 PM ET | MPM Oncology Impact Management LP | 13G | 5.60%2.67M shares | New | Dec 31, 2025 | SEC |
| Dec 15, 20257:56 PM ET | Ra Capital Management, L.P.and 5 others | 13D/A | 33.00%18.0M shares | – | Dec 11, 2025 | SEC |
| Oct 16, 20255:48 PM ET | AI Eti LLCand 3 others | 13D/A | 0.00%0 shares | −5.66 ppfrom 5.66%Below 5% | Oct 14, 2025 | SEC |
| Oct 7, 20254:51 PM ET | AI Eti LLCand 3 others | 13D/A | 5.66%3.84M shares | – | Oct 3, 2025 | SEC |
| Sep 18, 20259:26 AM ET | Pontifax Management 4 G.P. (2015) Ltd.and 3 others | 13G | 7.70%5.21M shares | New | Jun 27, 2024 | SEC |
| Feb 13, 20253:56 PM ET | BML Investment Partners, L.P.and 1 other | 13G/A | 0.00%0 shares | –Below 5% | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Deep Track Capital, LP | 13G/AOld format | – | – | – | SEC |
| Aug 16, 2024 | AI Eti LLC | 13D/AOld format | – | – | – | SEC |
| Aug 14, 2024 | Affinity Asset Advisors, LLC | 13G/AOld format | – | – | – | SEC |
| Jul 2, 2024 | Deep Track Capital, LP | 13GOld format | – | New | – | SEC |
| Jul 1, 2024 | Ra Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Jun 6, 2024 | Ra Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| May 17, 2024 | AI Eti LLC | 13D/AOld format | – | – | – | SEC |
| May 17, 2024 | Ra Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| May 7, 2024 | Affinity Asset Advisors, LLC | 13GOld format | – | New | – | SEC |
| Apr 12, 2024 | Ra Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Mar 18, 2024 | Ra Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 7, 2024 | BML Investment Partners, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 17, 2023 | Ra Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Nov 13, 2023 | AI Eti LLC | 13D/AOld format | – | – | – | SEC |
| Apr 10, 2023 | Ra Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Mar 8, 2023 | Intermediate Capital Group plc | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Samlyn Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2023 | BML Investment Partners, L.P. | 13G/AOld format | – | – | – | SEC |
| Sep 22, 2022 | ICG Life Sciences SCSp | 13GOld format | – | New | – | SEC |
| May 4, 2022 | BML Investment Partners, L.P. | 13GOld format | – | New | – | SEC |
| Apr 4, 2022 | Samlyn Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Samlyn Capital, LLC | 13GOld format | – | New | – | SEC |
| Aug 23, 2021 | AI Eti LLC | 13DOld format | – | New | – | SEC |
| Aug 19, 2021 | Ra Capital Management, L.P. | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
4 notices from officers, directors and other affiliates planning to sell Climb Bio, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Sep 15, 20264:27 PM ET | Stephen ThomasDirector | 100.0K | $1.46M | Sep 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 30, 20267:49 PM ET | Aoife BrennanOfficer · Director | 30.9K | $407.0K | Jun 29, 2026 | E-TRADE FINANCIAL CORPORATION | SEC |
| Feb 25, 20264:26 PM ET | Stephen ThomasDirector | 50.0K | $318.0K | Feb 25, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 12, 20264:28 PM ET | Stephen ThomasDirector | 100.0K | $556.0K | Feb 12, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |